Pemphigus foliaceus and pemphigus erythematosus

Christoph M. Hammers; Enno Schmidt; Luca Borradori

doi:10.1007/978-3-662-45139-7_69

Pemphigus foliaceus and pemphigus erythematosus

Christoph M. Hammers, Enno Schmidt^*, Luca Borradori

^*Korrespondierende/r Autor/-in für diese Arbeit

University of Bern

Abstract

Pemphigus foliaceus (PF) is a chronic autoimmune blistering disease of the skin, characterized by autoantibodies against a structural component of the epidermal desmosome, desmoglein 1 (Dsg1). Pemphigus erythematosus (PE; syn. Senear-Usher syndrome) is a localized form of PF with lesions typically developing on the face and the upper trunk and back. Management of pemphigus foliaceus does not greatly differ from that of pemphigus vulgaris. Systemic corticosteroids represent the mainstay of therapy and are usually combined with an immunosuppressive adjuvant.

Originalsprache	Englisch
Titel	European Handbook of Dermatological Treatments, Third Edition
Seitenumfang	10
Herausgeber (Verlag)	Springer Berlin Heidelberg
Erscheinungsdatum	01.01.2015
Seiten	691-700
ISBN (Print)	9783662451380
ISBN (elektronisch)	9783662451397
DOIs	https://doi.org/10.1007/978-3-662-45139-7_69
Publikationsstatus	Veröffentlicht - 01.01.2015

Strategische Forschungsbereiche und Zentren

Forschungsschwerpunkt: Infektion und Entzündung - Zentrum für Infektions- und Entzündungsforschung Lübeck (ZIEL)

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

Dokumente

10.1007/978-3-662-45139-7_69

Weitere Links

Link to publication in Scopus

Zitieren

@inbook{e0f921008c464bac86c669a052fa750d,

title = "Pemphigus foliaceus and pemphigus erythematosus",

abstract = "Pemphigus foliaceus (PF) is a chronic autoimmune blistering disease of the skin, characterized by autoantibodies against a structural component of the epidermal desmosome, desmoglein 1 (Dsg1). Pemphigus erythematosus (PE; syn. Senear-Usher syndrome) is a localized form of PF with lesions typically developing on the face and the upper trunk and back. Management of pemphigus foliaceus does not greatly differ from that of pemphigus vulgaris. Systemic corticosteroids represent the mainstay of therapy and are usually combined with an immunosuppressive adjuvant.",

author = "Hammers, {Christoph M.} and Enno Schmidt and Luca Borradori",

note = "Publisher Copyright: {\textcopyright} Springer-Verlag Berlin Heidelberg 2015.",

year = "2015",

month = jan,

day = "1",

doi = "10.1007/978-3-662-45139-7_69",

language = "English",

isbn = "9783662451380",

pages = "691--700",

booktitle = "European Handbook of Dermatological Treatments, Third Edition",

publisher = "Springer Berlin Heidelberg",

}

TY - CHAP

T1 - Pemphigus foliaceus and pemphigus erythematosus

AU - Hammers, Christoph M.

AU - Schmidt, Enno

AU - Borradori, Luca

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Pemphigus foliaceus (PF) is a chronic autoimmune blistering disease of the skin, characterized by autoantibodies against a structural component of the epidermal desmosome, desmoglein 1 (Dsg1). Pemphigus erythematosus (PE; syn. Senear-Usher syndrome) is a localized form of PF with lesions typically developing on the face and the upper trunk and back. Management of pemphigus foliaceus does not greatly differ from that of pemphigus vulgaris. Systemic corticosteroids represent the mainstay of therapy and are usually combined with an immunosuppressive adjuvant.

AB - Pemphigus foliaceus (PF) is a chronic autoimmune blistering disease of the skin, characterized by autoantibodies against a structural component of the epidermal desmosome, desmoglein 1 (Dsg1). Pemphigus erythematosus (PE; syn. Senear-Usher syndrome) is a localized form of PF with lesions typically developing on the face and the upper trunk and back. Management of pemphigus foliaceus does not greatly differ from that of pemphigus vulgaris. Systemic corticosteroids represent the mainstay of therapy and are usually combined with an immunosuppressive adjuvant.

UR - http://www.scopus.com/inward/record.url?scp=84944566860&partnerID=8YFLogxK

U2 - 10.1007/978-3-662-45139-7_69

DO - 10.1007/978-3-662-45139-7_69

M3 - Chapter

AN - SCOPUS:84944566860

SN - 9783662451380

SP - 691

EP - 700

BT - European Handbook of Dermatological Treatments, Third Edition

PB - Springer Berlin Heidelberg

ER -

Pemphigus foliaceus and pemphigus erythematosus

Abstract

Strategische Forschungsbereiche und Zentren

UN SDGs

Dokumente

Weitere Links

Fingerprint

Zitieren